(Q50889402)

24 March 2018

title

Effects of substance P on memory and mood in healthy male subjects. (English)

1 reference

24 March 2018

0 references

3

1 reference

24 March 2018

Klaus Lieb

6

object named as

Klaus Lieb

1 reference

24 March 2018

4

Bernd L Fiebich

1 reference

24 March 2018

Inga Herpfer

1

object named as

Inga Herpfer

1 reference

24 March 2018

Ulrich Voderholzer

5

object named as

Ulrich Voderholzer

1 reference

24 March 2018

author name string

Michael Katzev

2

1 reference

24 March 2018

publication date

1 December 2007

1 reference

24 March 2018

published in

Human Psychopharmacology

1 reference

24 March 2018

volume

22

1 reference

24 March 2018

page(s)

567-573

1 reference

24 March 2018

issue

8

1 reference

24 March 2018

An Inventory for Measuring Depression

cites work

1 reference

Substance P and neurodegenerative disorders. A speculative review

21 January 2018

1 reference

7 January 2021

Substance P serum levels are increased in major depression: preliminary results

1 reference

7 January 2021

Substance P: correlation of CSF and plasma levels

1 reference

7 January 2021

Stimulation of ACTH/Cortisol by Intravenously Infused Substance P in Normal Men: Inhibition by Sodium Valproate

1 reference

7 January 2021

Intravenously infused substance P is unable to change basal and TRH-stimulated PRL secretion in normal men

1 reference

7 January 2021

Acute cortisone administration impairs retrieval of long-term declarative memory in humans

1 reference

7 January 2021

Measurement of lactate-induced panic and anxiety.

1 reference

7 January 2021

Investigation of substance P transport across the blood-brain barrier

1 reference

7 January 2021

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

1 reference

7 January 2021

Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery

1 reference

7 January 2021

Substance P and Substance P Receptor Antagonists in the Pathogenesis and Treatment of Affective Disorders

1 reference

7 January 2021

Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential

1 reference

7 January 2021

A comparison of neurokinin 1 receptor knock-out (NK1-/-) and wildtype mice: exploratory behaviour and extracellular noradrenaline concentration in the cerebral cortex of anaesthetised subjects.

1 reference

7 January 2021

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

7 January 2021

Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression

1 reference

7 January 2021

Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men.

1 reference

7 January 2021

Serum levels of substance P and response to antidepressant pharmacotherapy

1 reference

7 January 2021

24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment.

1 reference

7 January 2021

Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life

1 reference

7 January 2021

Neurotransmitter functions of mammalian tachykinins

1 reference

7 January 2021

The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles

1 reference

7 January 2021

Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits

1 reference

7 January 2021

Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists

1 reference

7 January 2021

Flushing and plasma substance P concentration during infusion of synthetic substance P in normal man

1 reference

7 January 2021

Beta-endorphin, but not substance-P, is increased by acute stress in humans.

1 reference

7 January 2021

Serotonin and substance P co-exist in dorsal raphe neurons of the human brain

1 reference

7 January 2021

Neurokinin(1) receptor antagonists as potential antidepressants

1 reference

7 January 2021

Profiles of spontaneous 24-hour and stimulated growth hormone secretion in male patients with endogenous depression.

1 reference

7 January 2021

Studies in psychoneuroimmunology: psychological, immunological, and neuroendocrinological parameters in Israeli civilians during and after a period of Scud missile attacks.

1 reference

7 January 2021

1 reference

7 January 2021

Cortisol differentially affects memory in young and elderly men.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.876

1 reference

24 March 2018

PubMed ID

17768771

1 reference

24 March 2018